Fernando Doñate
Impact in
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
- Oncology top 5%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
- Genetics 12
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 8
- Chronic Lymphocytic Leukemia Research 4
-
- Cell Adhesion Molecules Research 9
- Co-authors
- Andrew Paul Mazar (18 shared papers)David Elliot Shaw (9 shared papers)Jose C. Juarez (6 shared papers)Xiaojun Guan (7 shared papers)Marian L. Plunkett (6 shared papers)Oscar Hernández Betancourt (3 shared papers)Mari Manuia (3 shared papers)Graham C. Parry (7 shared papers)
- Journals
- Molecular Cancer Therapeutics (9 papers)Cancer Research (5 papers)Clinical Cancer Research (5 papers)Annals of Oncology (4 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesCanadaSpain
In The Last Decade
Fernando Doñate
48 papers receiving 2.6k citations
Fernando Doñate's Hit Papers
Peers
Comparison fields: 5 of 111
- Immunology and Allergy 253
- Oncology 853
- Cancer Research 352
- Hematology 223
- Radiology, Nuclear Medicine and Imaging 353
Countries citing papers authored by Fernando Doñate
This map shows the geographic impact of Fernando Doñate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Doñate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Doñate more than expected).
Fields of papers citing papers by Fernando Doñate
This network shows the impact of papers produced by Fernando Doñate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Doñate. The network helps show where Fernando Doñate may publish in the future.
Co-authors
The 25 scholars most cited alongside Fernando Doñate, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Enfortumab Vedotin Antibody–Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models Hit paper breakdown → | 2016 | 558 |
| 2 | 2008 | 225 | |
| 3 | 2006 | 178 | |
| 4 | 2010 | 155 | |
| 5 | 2006 | 135 | |
| 6 | 2018 | 120 | |
| 7 | 2006 | 118 | |
| 8 | 2008 | 91 | |
| 9 | 2015 | 84 | |
| 10 | Histidine-proline-rich glycoprotein has potent antiangiogenic activity mediated through the histidine-proline-rich domain. | 2002 | 83 |
| 11 | 2008 | 81 | |
| 12 | 2017 | 76 | |
| 13 | Prostate-specific membrane antigen directed selective thrombotic infarction of tumors. | 2002 | 72 |
| 14 | 2008 | 67 | |
| 15 | 2017 | 65 | |
| 16 | 2016 | 58 | |
| 17 | 2018 | 51 | |
| 18 | 2002 | 50 | |
| 19 | 2004 | 48 | |
| 20 | 2004 | 45 |
About Fernando Doñate
Fernando Doñate is a scholar working on Genetics, Immunology and Allergy, Oncology, Hematology and Molecular Biology, having authored 49 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (9 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (8 papers), Angiogenesis and VEGF in Cancer (7 papers), Peptidase Inhibition and Analysis (6 papers), HER2/EGFR in Cancer Research (5 papers), Protease and Inhibitor Mechanisms (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Immunology and Allergy (253 citations), Oncology (853 citations), Cancer Research (352 citations), Hematology (223 citations) and Radiology, Nuclear Medicine and Imaging (353 citations). Fernando Doñate has collaborated with scholars based in United States, Canada and Spain. Frequent co-authors include Andrew Paul Mazar, David Elliot Shaw, Jose C. Juarez, Xiaojun Guan, Marian L. Plunkett, Oscar Hernández Betancourt, Mari Manuia, Graham C. Parry, Mark E. Burnett and Nicholas K. Tonks. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Clinical Cancer Research, Annals of Oncology and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.